Skip to main content
. 2016 Apr 14;11(4):e0153502. doi: 10.1371/journal.pone.0153502

Fig 2. Risk of cardiovascular events between patients with type 2 diabetes mellitus with no other complications treated with incretin or control.

Fig 2